The 2018 Ottawa-Gatineau march for Multiple Myeloma is happening on September 23rd.
I am writing to invite you to join us again this year in the annual walk to support Multiple Myeloma (MM) research. Last year’s Ottawa-Gatineau March was a huge success raising close to $75,000. I have been able to contribute over $10,000 thanks to your generosity!
When I was first diagnosed with MM in 2015, I was told that the average life span with the disease was 5 years! However, many patients survive much longer and I am determined to beat the odds. I had a stem cells transplant and I am in good shape. And I continue to do well on my current drug protocol. My cancer numbers have been reduced significantly with relatively few side effects. Good news! Unfortunately, the timeline for the effectiveness of the protocol is limited. I am hoping that new research and new drugs will be available to ensure that my current level of remission is sustainable. A cure would be perfect!
While research continues into effective treatments for the disease and promising drugs are on the horizon, MM remains a relatively unknown and incurable form of blood cancer. Supporting research and raising awareness of the disease is critical. Not only does this research immediately benefit MM patients (and I am an example!) but it contributes to our broader understanding of the causation and treatments for a variety of other cancers.
So I am asking you to support me again this year. Our 2018 Ottawa-Gatineau Multiple Myeloma Walk…Steps to a Cure! has set a fundraising goal of $85,000. With your help, my goal is to collect again $10,000 this year.
To make a contribution, please click on 'Donate Now', higher right. A tax receipt will be emailed to you for donations of $ 25 and up.
If you would like to join me for the walk, call me at 819-430-8996
Here are the coordinates :
Ron Kolbus-Lakeside Center
102 Greenview Avenue
Sunday, September 23, 2018
Registration at 12: 30h
March from 13h to 15h - 5 kilometers.
Thank you again for your continued support!
If you think this page contains objectionable content, please inform the system administrator.